Shanghai Pharmaceuticals Holding Co (SHSE:601607) 3-Year EBITDA Growth Rate : -7.20% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co 3-Year EBITDA Growth Rate?

Shanghai Pharmaceuticals Holding Co's EBITDA per Share for the three months ended in Dec. 2023 was ¥0.26.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average EBITDA Per Share Growth Rate was -17.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shanghai Pharmaceuticals Holding Co was 66.90% per year. The lowest was -21.50% per year. And the median was 10.30% per year.

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate falls into.

Shanghai Pharmaceuticals Holding Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Shanghai Pharmaceuticals Holding Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines